These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2109198)

  • 1. ddI--a good start, but still phase I.
    Fauci AS
    N Engl J Med; 1990 May; 322(19):1386-8. PubMed ID: 2109198
    [No Abstract]   [Full Text] [Related]  

  • 2. Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial.
    Cooley TP; Kunches LM; Saunders CA; Ritter JK; Perkins CJ; McLaren C; McCaffrey RP; Liebman HA
    N Engl J Med; 1990 May; 322(19):1340-5. PubMed ID: 2139174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial.
    Lambert JS; Seidlin M; Reichman RC; Plank CS; Laverty M; Morse GD; Knupp C; McLaren C; Pettinelli C; Valentine FT
    N Engl J Med; 1990 May; 322(19):1333-40. PubMed ID: 2139173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New ddI information.
    Randall PS
    Minn Med; 1990 Dec; 73(12):12. PubMed ID: 2127299
    [No Abstract]   [Full Text] [Related]  

  • 5. Promising results for new AIDS/ARC drug.
    Nurs Stand; 1990 Jun 13-19; 4(38):16. PubMed ID: 2116821
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS treatment: 'parallel trick' for ddI.
    McGourty C
    Nature; 1989 Oct; 341(6242):474. PubMed ID: 2507927
    [No Abstract]   [Full Text] [Related]  

  • 7. New drug therapy for patients with HIV. Nursing implications in the administration of 2',3'-dideoxyinosine (ddI).
    Shay LE; Thomas RV; Wyvill KM; Adamo DO; Jenkins JF
    Cancer Nurs; 1990 Oct; 13(5):269-77. PubMed ID: 2123127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine.
    Kieburtz KD; Seidlin M; Lambert JS; Dolin R; Reichman R; Valentine F
    J Acquir Immune Defic Syndr (1988); 1992; 5(1):60-4. PubMed ID: 1346633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1989 Nov; 262(18):2503. PubMed ID: 2509741
    [No Abstract]   [Full Text] [Related]  

  • 10. 2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complex.
    Dolin R; Lambert JS; Morse GD; Reichman RC; Plank CS; Reid J; Knupp C; McLaren C; Pettinelli C
    Rev Infect Dis; 1990; 12 Suppl 5():S540-9; discussion S549-51. PubMed ID: 1974726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS drug update: DDI and DDC.
    Anastasi JK; Rivera JL
    RN; 1991 Nov; 54(11):41-3. PubMed ID: 1658917
    [No Abstract]   [Full Text] [Related]  

  • 12. DdI for AIDS patients intolerant to AZT.
    Am Pharm; 1991 Dec; NS31(12):10. PubMed ID: 1763769
    [No Abstract]   [Full Text] [Related]  

  • 13. The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profiles.
    Yarchoan R; Mitsuya H; Pluda JM; Marczyk KS; Thomas RV; Hartman NR; Brouwers P; Perno CF; Allain JP; Johns DG
    Rev Infect Dis; 1990; 12 Suppl 5():S522-33. PubMed ID: 1974724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of 2',3'-dideoxyinosine: experience with 19 patients at New York University Medical Center.
    Valentine FT; Seidlin M; Hochster H; Laverty M
    Rev Infect Dis; 1990; 12 Suppl 5():S534-9. PubMed ID: 1974725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patients.
    Rozencweig M; McLaren C; Beltangady M; Ritter J; Canetta R; Schacter L; Kelley S; Nicaise C; Smaldone L; Dunkle L
    Rev Infect Dis; 1990; 12 Suppl 5():S570-5. PubMed ID: 2166965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDI clinical trials.
    Am Fam Physician; 1990 Oct; 42(4):1120. PubMed ID: 2121009
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine.
    Grasela TH; Walawander CA; Beltangady M; Knupp CA; Martin RR; Dunkle LM; Barbhaiya RH; Pittman KA; Dolin R; Valentine FT
    J Infect Dis; 1994 Jun; 169(6):1250-5. PubMed ID: 8195601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoside therapy for HIV infection--some answers, many questions.
    Groopman JE; Molina JM
    N Engl J Med; 1992 Aug; 327(9):639-41. PubMed ID: 1640958
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA expands testing of anti-AIDS drugs.
    N Y State J Med; 1989 Sep; 89(9):548. PubMed ID: 2552360
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-HIV therapy (1987-1994): from nothing to confusion].
    Lissen E
    Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.